Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
Central South University · Xiangya Hospital Central South University
Abstract
The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions.
Based on recently published literature, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Citation impact
- FWCI
- 11.57
- Percentile
- 100%
- References
- 58
Authors
2Topics & keywords
- Interim
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- 2019-20 coronavirus outbreak
- Coronavirus
- Betacoronavirus
- Virology
- Middle East respiratory syndrome coronavirus
- Good health and well-being